Monetta Financial Services’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.49M Buy
+5,700
New +$1.46M 1% 27
2024
Q2
– Sell
-5,700
Closed -$1.04M – 48
2024
Q1
$1.04M Hold
5,700
– – 0.94% 27
2023
Q4
$883K Buy
+5,700
New +$831K 0.84% 35
2022
Q3
– Sell
-4,000
Closed -$613K – 56
2022
Q2
$613K Sell
4,000
-2,000
-33% -$306K 0.64% 34
2022
Q1
$973K Hold
6,000
– – 0.81% 25
2021
Q4
$812K Buy
+6,000
New +$709K 0.63% 32
2016
Q4
– Sell
-27,500
Closed -$1.73M – 60
2016
Q3
$1.73M Hold
27,500
– – 1.11% 33
2016
Q2
$1.7M Buy
+27,500
New +$1.68M 1.08% 33

Other funds holding ABBV

Monetta Financial Services's ABBV Position: Q3 2026 in Review

Monetta Financial Services opened a new position in AbbVie (ABBV) in Q3 2026: 5,700 shares worth $1.49M. The stake represents 1% of the portfolio and ranks #27 among its holdings. This is a return to the name: Monetta Financial Services previously reported a position in ABBV as recently as Q1 2024.

Monetta Financial Services first reported a position in ABBV in Q2 2016 and has held it in 8 quarters since. The position peaked at $1.73M in Q3 2016. 3,830 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Monetta Financial Services held 5,700 shares of AbbVie worth $1.49M as of Q3 2026.
  • AbbVie was a new Monetta Financial Services position in Q3 2026.
  • AbbVie made up 1% of Monetta Financial Services's portfolio in Q3 2026, its #27 holding.
  • Monetta Financial Services first reported a position in AbbVie in Q2 2016 and has held it in 8 quarters since.
  • Monetta Financial Services's AbbVie position peaked at $1.73M in Q3 2016.
  • 3,830 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Monetta Financial Services's 13F filing for Q3 2026, filed 12 Nov 2026.